TriSalus Life Sciences, Inc.(TLSI US)
$2.85-0.3711.49%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 11.8 | 8.5 | 20.4 | 56.6 | |||||
| Short Term Investments | - | - | - | - | |||||
| Cash and Short Term Investments | 11.8 | 8.5 | 20.4 | 56.6 | |||||
| Net Receivables | 3.6 | 5.1 | 6.6 | 5.2 | |||||
| Inventory | 2.5 | 4.0 | 3.1 | 3.8 | |||||
| Other Current Assets | - | - | - | 2.6 | |||||
| Total Current Assets | 20.9 | 20.7 | 32.2 | 68.1 | |||||
| Property, Plant & Equipment | 3.3 | 2.9 | 2.7 | 2.8 | |||||
| Long Term Investments | - | 0.4 | 0.4 | - | |||||
| Other Non-Current Assets | 0.5 | 0.1 | 0.0 | 0.1 | |||||
| Total Non-Current Assets | 3.7 | 3.3 | 3.1 | 2.8 | |||||
| Total Assets | 24.6 | 24.0 | 35.3 | 71.0 | |||||
| Account Payables | 3.4 | 2.3 | 3.0 | 4.2 | |||||
| Short Term Debt | - | - | 0.2 | - | |||||
| Deferred Revenue | - | - | - | - | |||||
| Other Current Liabilities | 0.4 | 0.4 | 8.2 | 0.3 | |||||
| Total Current Liabilities | 14.7 | 10.2 | 11.5 | 11.8 | |||||
| Long Term Debt | - | 22.1 | 34.3 | 34.3 | |||||
| Other Non-Current Liabilities | 35.7 | 16.2 | 23.4 | 12.1 | |||||
| Total Non-Current Liabilities | 37.0 | 39.6 | 57.7 | 46.4 | |||||
| Total Liabilities | 51.7 | 49.9 | 69.2 | 58.2 | |||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | |||||
| Retained Earnings | -249.5 | -279.5 | -330.6 | -329.0 | |||||
| Total Stockholders Equity | -27.1 | -25.9 | -33.9 | 12.8 | |||||
| Total Liabilities and Equity | 24.6 | 24.0 | 35.3 | 71.0 | |||||
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 11.8 | 8.5 | 20.4 | 56.6 | |||||
| Short Term Investments | - | - | - | - | |||||
| Cash and Short Term Investments | 11.8 | 8.5 | 20.4 | 56.6 | |||||
| Net Receivables | 3.6 | 5.1 | 6.6 | 5.2 | |||||
| Inventory | 2.5 | 4.0 | 3.1 | 3.8 | |||||
| Other Current Assets | - | - | - | 2.6 | |||||
| Total Current Assets | 20.9 | 20.7 | 32.2 | 68.1 | |||||
| Property, Plant & Equipment | 3.3 | 2.9 | 2.7 | 2.8 | |||||
| Long Term Investments | - | 0.4 | 0.4 | - | |||||
| Other Non-Current Assets | 0.5 | 0.1 | 0.0 | 0.1 | |||||
| Total Non-Current Assets | 3.7 | 3.3 | 3.1 | 2.8 | |||||
| Total Assets | 24.6 | 24.0 | 35.3 | 71.0 | |||||
| Account Payables | 3.4 | 2.3 | 3.0 | 4.2 | |||||
| Short Term Debt | - | - | 0.2 | - | |||||
| Deferred Revenue | - | - | - | - | |||||
| Other Current Liabilities | 0.4 | 0.4 | 8.2 | 0.3 | |||||
| Total Current Liabilities | 14.7 | 10.2 | 11.5 | 11.8 | |||||
| Long Term Debt | - | 22.1 | 34.3 | 34.3 | |||||
| Other Non-Current Liabilities | 35.7 | 16.2 | 23.4 | 12.1 | |||||
| Total Non-Current Liabilities | 37.0 | 39.6 | 57.7 | 46.4 | |||||
| Total Liabilities | 51.7 | 49.9 | 69.2 | 58.2 | |||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | |||||
| Retained Earnings | -249.5 | -279.5 | -330.6 | -329.0 | |||||
| Total Stockholders Equity | -27.1 | -25.9 | -33.9 | 12.8 | |||||
| Total Liabilities and Equity | 24.6 | 24.0 | 35.3 | 71.0 | |||||